We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genentech Gets Untitled Letter for Consumer-Directed Herceptin Video
Genentech Gets Untitled Letter for Consumer-Directed Herceptin Video
April 26, 2010
The FDA has issued an untitled letter to Genentech for a patient video that overstates the efficacy of its breast cancer drug Herceptin and minimizes its risks.